HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koji Ohashi Selected Research

SA 3443

11/2005Suppression of laser-induced choroidal neovascularization by oral administration of SA3443 in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koji Ohashi Research Topics

Disease

22Obesity
07/2018 - 09/2003
20Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 06/2005
13Ischemia
12/2021 - 10/2005
12Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2022 - 06/2003
10Hypertension (High Blood Pressure)
07/2022 - 06/2003
10Hypoxia (Hypoxemia)
12/2021 - 11/2005
10Inflammation (Inflammations)
01/2021 - 05/2004
9Myocardial Infarction
12/2021 - 10/2005
8Fibrosis (Cirrhosis)
01/2022 - 09/2007
8Insulin Resistance
01/2022 - 06/2003
6Non-alcoholic Fatty Liver Disease
08/2022 - 09/2013
6Myocardial Ischemia (Ischemic Heart Diseases)
12/2021 - 10/2005
6Coronary Artery Disease (Coronary Atherosclerosis)
01/2017 - 02/2003
6Type 2 Diabetes Mellitus (MODY)
10/2010 - 06/2003
5Dyslipidemias (Dyslipidemia)
01/2021 - 06/2003
5Hypoadiponectinemia
01/2021 - 06/2003
5Cardiomegaly (Heart Hypertrophy)
11/2019 - 12/2004
5Reperfusion Injury
12/2018 - 10/2005
5Hypertrophy
03/2015 - 12/2004
4Heart Failure
02/2022 - 08/2010
4Body Weight (Weight, Body)
01/2021 - 01/2010
4Chronic Renal Insufficiency
04/2020 - 01/2011
4Atherosclerosis
10/2012 - 11/2002
3Hyperlipidemias (Hyperlipidemia)
01/2022 - 06/2003
3Necrosis
01/2022 - 05/2016
3Neoplasms (Cancer)
01/2022 - 05/2019
3Infarction (Infarctions)
01/2019 - 10/2005
2Retinal Degeneration
01/2022 - 12/2019
2Atrophy
01/2022 - 01/2017
2Left Ventricular Dysfunction
03/2015 - 01/2014
2Albuminuria
03/2015 - 09/2007
2Alcoholic Fatty Liver
01/2015 - 09/2013
2Vascular System Injuries
07/2014 - 01/2013
2Retinal Neovascularization
01/2010 - 05/2009
2Pathologic Neovascularization
01/2010 - 05/2009
1Fatty Liver
08/2022
1Diabetes Mellitus
08/2022
1Muscular Atrophy (Muscle Atrophy)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Thrombosis (Thrombus)
01/2022
1Abdominal Aortic Aneurysm
01/2022
1Atrial Fibrillation
01/2022

Drug/Important Bio-Agent (IBA)

34AdiponectinIBA
01/2022 - 11/2002
20Proteins (Proteins, Gene)FDA Link
03/2022 - 11/2005
17AdipokinesIBA
10/2017 - 12/2004
8Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2013
8MicroRNAs (MicroRNA)IBA
07/2022 - 09/2013
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2017 - 10/2005
5FructoseIBA
01/2021 - 05/2012
5AMP-Activated Protein KinasesIBA
06/2014 - 12/2004
4Glucose (Dextrose)FDA LinkGeneric
08/2022 - 07/2010
4Angiotensin IIIBA
01/2022 - 05/2008
4Triglycerides (Triacylglycerol)IBA
12/2021 - 01/2015
4FollistatinIBA
12/2021 - 10/2011
4HDL CholesterolIBA
12/2021 - 01/2015
4LipopolysaccharidesIBA
01/2020 - 10/2012
4CytokinesIBA
03/2016 - 10/2005
3Nonesterified Fatty Acids (NEFA)IBA
12/2021 - 06/2012
3EnzymesIBA
12/2021 - 11/2005
3Lipid PeroxidesIBA
01/2021 - 01/2013
3Messenger RNA (mRNA)IBA
05/2016 - 11/2005
3Glycoproteins (Glycoprotein)IBA
01/2016 - 03/2010
3AlbuminsIBA
03/2015 - 09/2007
3NADPH Oxidases (NAD(P)H oxidase)IBA
03/2015 - 09/2007
3Blood Proteins (Serum Proteins)IBA
01/2010 - 04/2008
2LipidsIBA
08/2022 - 06/2015
2ApolipoproteinsIBA
01/2022 - 11/2002
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2021
2Nerve Growth Factors (Neurotrophins)IBA
01/2022 - 03/2015
2Insulin (Novolin)FDA Link
01/2021 - 05/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 11/2005
2Pharmaceutical PreparationsIBA
01/2020 - 11/2019
2Vitamin EFDA LinkGeneric
01/2020 - 01/2013
2InterleukinsIBA
01/2020 - 06/2017
2Protein Kinases (Protein Kinase)IBA
11/2019 - 07/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019 - 09/2011
2MyokinesIBA
12/2018 - 09/2016
2Interleukin-6 (Interleukin 6)IBA
05/2016 - 01/2014
2Hormones (Hormone)IBA
01/2014 - 01/2010
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
09/2013 - 01/2012
1Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2022
1ORALIT (ORS)IBA
07/2022
1rat MIRN27 microRNAIBA
07/2022
1Circulating MicroRNAIBA
07/2022
1ThioredoxinsIBA
03/2022
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
02/2022
1SteroidsIBA
01/2022
1edoxabanIBA
01/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2022
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2022
1UbiquitinIBA
01/2022
1Factor Xa (Coagulation Factor Xa)IBA
01/2022
1High Fructose Corn SyrupIBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
12/2021
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
12/2021

Therapy/Procedure

3Oral Administration
02/2022 - 11/2005
2Nephrectomy
01/2022 - 03/2015
2Ligation
01/2019 - 03/2015
2Therapeutics
06/2014 - 06/2006
1Denervation
01/2022